Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
Following publication of the original article [1], the authors reported that there was an error in Figure 9, which contained a misplaced picture. The authors confirm that all of the published results and conclusions of the paper remain unchanged, as well as the figure legends. The authors apologize...
Main Authors: | Gang Chen, Peter Kronenberger, Erik Teugels, Ijeoma Adaku Umelo, Jacques De Grève |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | BMC Medicine |
Online Access: | https://doi.org/10.1186/s12916-020-1501-8 |
Similar Items
-
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
by: Chen Gang, et al.
Published: (2012-03-01) -
Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib.
by: Gang Chen, et al.
Published: (2013-01-01) -
Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells
by: Chen Gang, et al.
Published: (2010-11-01) -
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.
by: Gang Chen, et al.
Published: (2013-01-01) -
Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment
by: Liang H, et al.
Published: (2018-09-01)